期刊文献+

碳青霉烯类抗生素的神经毒性 被引量:59

Neurotoxicity of carbapenem antibiotics
原文传递
导出
摘要 碳青霉烯类是一类具有广谱抗菌作用的β-内酰胺类抗生素。其常用药物包括亚胺培南、美罗培南、厄他培南、法罗培南、帕尼培南和多尼培南等。此类药物可诱发神经毒性,发生率约为0.01%~3%。神经毒性主要临床表现为头痛、惊厥、癫痫、肌阵挛、意识障碍等。神经毒性的发生机制为碳青霉烯类抗生素阻止γ-氨基丁酸(γ-GABA)与受体的结合,从而干扰γ-GABA的神经抑制作用,导致癫痫等神经毒性发生。神经毒性反应的危险因素包括患者肾功能减退、中枢神经系统病变、合并用药等。防治措施:根据不同种类碳青霉烯类抗生素与癫痫的相关性合理选择药物;应谨慎调整肾衰竭患者的使用剂量;避免与高剂量茶碱、非甾体抗炎药及丙磺舒等合用;儿童及老年患者用药过程中应进行监测;一旦出现癫痫发作应立即停药,必要时可选用地西泮或丙戊酸钠治疗;癫痫无法控制者可用血液透析治疗。 Carbapenems are a class of β-lactam antibiotics with a broad spectum of antibacterial activity. The commonly used carbapenems are imipenem,meropenem,ertapenem,faropenem,panipenem,doripenem,and so on. Carbapenem antibiotics could induce neurotoxicity and the incidence is about 0. 01% -0. 3% . The main clinical manifestations of neurotoxicity are headache, convulsions,seizures,myoclonus,and disorder of consciousness. The mechanism of neurotoxicity induced by carbapenem antibiotics is thought to be related to inhibition of the γ-aminobutyric acid ( γ-GABA) binding to the receptors and interruption neural inhibitory effect of γ-GABA eventally resulting in seizures and other neurological disorders. The risk factors for neurotoxic reactions include decreased renal function,pathologic changes in CNS,and combination therapy. The prevention and treatment of neurotoxicity induced by carbapenems are as follows: it is essential to consider appropriate choice of carbapenem antibiotics according to the relationship between seizures and the different types of the antibiotics; dosage should be carefully adjusted in patients with renal failure; concomitant use with other drugs such as high-dose theophylline,NSAIDs,probenecid,and so on should be avoided; the children and elderly patients should be monitored during treatment; if carbapenem-induced seizures occur,the agent should be stopped and diazepam or sodium valproate may be given if necessary; hemodialysis could be used for patients with uncontrolled seizures induced by the antibiotics.
作者 马莉莉 张健
出处 《药物不良反应杂志》 2010年第3期178-182,共5页 Adverse Drug Reactions Journal
关键词 碳青霉烯类抗生素 不良反应 神经毒性 carbapenem antibiotics adverse reactions neurotoxicity
  • 相关文献

参考文献28

  • 1Wallace KL. Antibiotic-induced convulsions [ J ]. Crit Care Clin, 1997,13(4) :741-763.
  • 2Koppel BS, Hauser WA, Politis C, et al. Seizures in the Critically III: The Role of Imipenem [ J ]. Epilepsia, 2001, 42(12) :1590 - 1593.
  • 3Livermore DM, Sefton AM, Scott GM. Properties and potential of ertapenem [ J ]. J Antimicrob Chemother, 2003, 52(3) :331 -344.
  • 4Scfaliamser SE, Brobohn KA, Liljedahl AL, et al. Comparative neurotoxicity of benzylpenicillin, imipenem/ cilastatin and FCE 22101, a new injectible penem[ J]. J Antimicrob Chemother, 1988, 22 (5) :687-695.
  • 5Cirillo I, Vaccaro N, Solanki B, et al. Pharmacokinetics, safety, and tolerability of doripenem after 0.5-, 1-, and 4-hour infusions in healthy volunteers [ J ]. J Clin Pharmacol, 2009, 49 (7) : 798-806.
  • 6Paterson DL, Depestel DD. Doripenem [ J ]. Clin Infect Dis, 2009, 49(2) :291 - 298.
  • 7Mandell L. Doripenem: a new carbapenem in the treatment of nosocomial infection[ J ]. Clin Infect Dis, 2009, 49(Suppl 1) :S1 -S3.
  • 8Redman R, File TM. Safety of intravenous infusion of doripenem[J]. Clin Infect Dis, 2009, 49 (Suppl 1): S28-S35.
  • 9Matthews SJ, Lancaster JW. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic [ J ]. Clin Ther, 2009, 31 ( 1 ) :42-63.
  • 10Lister PD. Carbapenems in the USA: focus on doripenem [J]. Expert Rev Anti Infect Ther, 2007, 5(5):793- 809.

二级参考文献6

  • 1Somani P, Freimer E, Gross M, et al. Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis[J]. Antimicrobial Agents and Chemotherapy, 1988,32:530.
  • 2Sharon RS, Glenn RH. The neurotoxicity of antibacterial agents[J]. An Internal Med, 1984, 101:92.
  • 3Aronoff GR, Brier ME, Erbeck KM, et al. Drug dosing in dialysis patients. In: Owen WF, Pereira BG, Sayegh MH, eds. Dialysis and Transplantation[M]. 2001:358-372.
  • 4Martinez-Rodriguez JE, Barriga F J, Santamaria J, et al.Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure [J]. Am J Med,2001, 111:115.
  • 5Jackson GD, Berkovic SF. Ceftazidime encephalopathy:absence status and toxic hallucinations [J]. J Neurol Neurosurg Psychiatry, 1992, 55: 333.
  • 6Verbish L, Verpooten GA, Guiliano RA, et al. Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure[J]. J Antimicrob Chemother, 1986, 18(suppl):E115.

共引文献24

同被引文献432

引证文献59

二级引证文献225

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部